The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin

Critical Reviews in Toxicology - Tập 40 Số 4 - Trang 347-359 - 2010
Anamaria Brozović1, Andreja Ambriović‐Ristov1, Maja Osmak1
1Laboratory for Genotoxic Agents, Division of Molecular Biology, Rudjer Boskovic Institute, Zagreb, Croatia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adams JM, 2007, Curr Opin Immunol, 19, 488, 10.1016/j.coi.2007.05.004

Aggarwal SK, 1983, J Histochem Cytochem, 31, 307, 10.1177/31.2.6300219

Akaboshi M, 1992, Jpn J Cancer Res, 83, 522, 10.1111/j.1349-7006.1992.tb01959.x

Armstrong JS, 2002, FASEB J, 16, 1263, 10.1096/fj.02-0097fje

10.1016/S0092-8674(85)80070-2

Ballatori N, 2009, Mol Aspects Med, 30, 13, 10.1016/j.mam.2008.08.004

Beale PJ, 2000, Br J Cancer, 82, 436, 10.1054/bjoc.1999.0939

10.1074/jbc.M408531200

Berndtsson M, 2007, Int J Cancer, 120, 175, 10.1002/ijc.22132

Berners-Price SJ, 1990, J Inorg Biochem, 38, 327, 10.1016/0162-0134(90)80006-J

Boulikas T, 2003, Oncol Rep, 10, 1663

Bragado P, 2007, Apoptosis, 12, 1733, 10.1007/s10495-007-0082-8

Brozovic A, 2009, Mutat Res, 670, 32, 10.1016/j.mrfmmm.2009.07.002

Brozovic A, 2004, Int J Cancer, 112, 974, 10.1002/ijc.20522

Brozovic A, 2008, Mol Pharmacol, 74, 298, 10.1124/mol.107.043836

Brozovic A, 2007, Cancer Lett, 251, 1, 10.1016/j.canlet.2006.10.007

Buttke TM, 1995, Free Radic Res, 22, 389, 10.3109/10715769509147548

10.1111/j.1464-410X.2005.05472.x

Celli A, 1998, Am J Physiol, 275, G749

Chen ZX, 2007, Cell Death Differ, 14, 1617, 10.1038/sj.cdd.4402165

10.1016/j.canlet.2005.05.039

Cowley EA, 2002, J Physiol, 543, 201, 10.1113/jphysiol.2002.022400

Custodio JB, 2009, Toxicology, 259, 18, 10.1016/j.tox.2009.01.022

D’Alessio M, 2004, FASEB J, 18, 1609, 10.1096/fj.04-1813fje

Danial NN., 2007, Clin Cancer Res, 13, 7254, 10.1158/1078-0432.CCR-07-1598

Daubeuf S, 2003, Biochem Pharmacol, 66, 595, 10.1016/S0006-2952(03)00343-5

Daubeuf S, 2002, Biochem Pharmacol, 64, 207, 10.1016/S0006-2952(02)01118-8

Dickinson DA, 2002, Biochem Pharmacol, 64, 1019, 10.1016/S0006-2952(02)01172-3

Dimanche-Boitrel MT, 2005, Drug Resist Updat., 8, 5, 10.1016/j.drup.2005.02.003

10.1080/10408360500523878

Filomeni G, 2002, Biochem Pharmacol, 64, 1057, 10.1016/S0006-2952(02)01176-0

Franco R, 2009, Cell Death Differ, 16, 1303, 10.1038/cdd.2009.107

Franzini M, 2006, Eur J Cancer, 42, 2623, 10.1016/j.ejca.2006.04.016

Fuertes MA, 2002, Curr Med Chem Anticancer Agents, 2, 539, 10.2174/1568011023353958

Galanski M., 2006, Recent Pat Anticancer Drug Discov, 1, 285, 10.2174/157489206777442287

Germain M, 2003, Sci STKE, 2003, 10, 10.1126/stke.2003.173.pe10

Ghazal-Aswad S, 1996, Br J Cancer, 74, 468, 10.1038/bjc.1996.384

Giardino I, 1996, J Clin Invest, 97, 1422, 10.1172/JCI118563

10.2174/138161206779010549

Godwin AK, 1992, Proc Natl Acad Sci U S A, 89, 3070, 10.1073/pnas.89.7.3070

10.1111/j.1349-7006.2002.tb02482.x

Grunicke H, 1992, Pharmacol Ther, 55, 1, 10.1016/0163-7258(92)90027-W

Hanigan MH, 1999, Carcinogenesis, 20, 553, 10.1093/carcin/20.4.553

Hao XY, 1994, Carcinogenesis, 15, 1167, 10.1093/carcin/15.6.1167

Havelka AM, 2007, Mini Rev Med Chem, 7, 1035, 10.2174/138955707782110196

Herod JJ, 1996, Cancer Res, 56, 2178

Hill JM, 1975, Cancer Chemother Rep, 59, 647

Hill JM, 1982, Anticancer Res, 2, 173

Hill NO., 1979, N Engl J Med, 301, 47

Hochman A, 2000, Cell Mol Biol (Noisy-le-grand), 46, 41

Hockenbery DM, 1993, Cell, 75, 241, 10.1016/0092-8674(93)80066-N

Hoffmann S, 2004, Free Radic Biol Med, 36, 765, 10.1016/j.freeradbiomed.2003.12.019

Hopkins FG, 1936, Biochem J, 30, 1446, 10.1042/bj0301446

Hopkins FG, 1938, Biochem J, 32, 611, 10.1042/bj0320611

Huang HL, 2003, Oncogene, 22, 8168, 10.1038/sj.onc.1206979

Huang Z, 2003, Cancer Cell Int, 3, 5, 10.1186/1475-2867-3-5

10.2174/0929867033456477

Ise T, 2005, J Membr Biol, 205, 139, 10.1007/s00232-005-0779-y

Ishikawa T., 1992, Trends Biochem Sci, 17, 463, 10.1016/0968-0004(92)90489-V

Ishikawa T, 1994, J Biol Chem, 269, 29085, 10.1016/S0021-9258(19)62016-8

10.1016/S0968-0004(96)20008-8

Jing XB, 2007, Biochem Cell Biol, 85, 265, 10.1139/O07-014

10.1126/science.8235659

Kim R, 2004, Cancer, 101, 2177, 10.1002/cncr.20636

Kolfschoten GM, 2000, Gynecol Oncol, 76, 362, 10.1006/gyno.1999.5689

Komatsu M, 2000, Cancer Res, 60, 1312

Konishi I, 1998, Gynecol Oncol, 70, 365, 10.1006/gyno.1998.5077

Kroemer G, 2007, Physiol Rev, 87, 99, 10.1152/physrev.00013.2006

Kruidering M, 1997, J Pharmacol Exp Ther, 280, 638

Lacour S, 2004, Cancer Res, 64, 3593, 10.1158/0008-5472.CAN-03-2787

Landriscina M, 2009, Antioxid Redox Signal, 11, 2701, 10.1089/ars.2009.2692

Lee EL, 2008, Am J Physiol Cell Physiol, 294, 1398, 10.1152/ajpcell.00428.2007

Lee M, 2001, Free Radic Biol Med, 31, 1550, 10.1016/S0891-5849(01)00633-5

10.4161/auto.6260

Li F, 2005, Biochem Biophys Res Commun, 335, 1070, 10.1016/j.bbrc.2005.07.169

Lin CS, 2008, Interact Cardiovasc Thorac Surg, 7, 954, 10.1510/icvts.2008.177006

Losert D, 2007, Anticancer Drugs, 18, 755, 10.1097/CAD.0b013e3280adc8c8

Lu AL, 2001, Cell Biochem Biophys, 35, 141, 10.1385/CBB:35:2:141

Lu SC, 1992, Am J Physiol, 263, C1181, 10.1152/ajpcell.1992.263.6.C1181

Mandic A, 2003, J Biol Chem, 278, 9100, 10.1074/jbc.M210284200

Markovic J, 2007, J Biol Chem, 282, 20416, 10.1074/jbc.M609582200

Martins NM, 2008, J Appl Toxicol, 28, 337, 10.1002/jat.1284

10.1006/bbrc.1994.2306

Meijer C, 1990, Br J Cancer, 62, 72, 10.1038/bjc.1990.232

10.1016/0076-6879(95)51106-7

10.1006/bbrc.1998.8998

Meyer TE, 1998, Int J Cancer, 77, 55, 10.1002/(SICI)1097-0215(19980703)77:1<55::AID-IJC10>3.0.CO;2-8

Michaud WA, 2009, Clin Cancer Res, 15, 1645, 10.1158/1078-0432.CCR-08-2581

Mirkovic N, 1997, Oncogene, 15, 1461, 10.1038/sj.onc.1201310

Miyajima A, 1997, Br J Cancer, 76, 206, 10.1038/bjc.1997.363

Miyatake K, 2003, Anticancer Res, 23, 2829

Nichols TC, 1998, Eur J Immunol, 28, 4123, 10.1002/(SICI)1521-4141(199812)28:12<4123::AID-IMMU4123>3.0.CO;2-G

Nishimura T, 1996, Clin Cancer Res, 2, 1859

Nunez G, 1990, J Immunol, 144, 3602, 10.4049/jimmunol.144.9.3602

Osbild S, 2006, Anticancer Res, 26, 3595

Paschen W., 2001, Cell Calcium, 29, 1, 10.1054/ceca.2000.0162

Paschen W., 2003, Cell Calcium, 34, 365, 10.1016/S0143-4160(03)00139-8

Poulsen HE, 2000, Free Radic Res, 33, S33

Previati M, 2006, Int J Mol Med, 18, 511

Rabik CA, 2007, Cancer Treat Rev, 33, 9, 10.1016/j.ctrv.2006.09.006

Rahman I, 2000, Free Radic Biol Med, 28, 1405, 10.1016/S0891-5849(00)00215-X

Rebillard A, 2008, Curr Med Chem, 15, 2656, 10.2174/092986708786242903

Rudin CM, 2008, J Natl Compr Canc Netw, 6, 315, 10.6004/jnccn.2008.0026

Rudin CM, 2003, Cancer Res, 63, 312

10.1124/dmd.30.2.183

Safaei R, 2005, Crit Rev Oncol Hematol, 53, 13, 10.1016/j.critrevonc.2004.09.007

Saitoh Y, 2003, J Cell Biochem, 89, 321, 10.1002/jcb.10506

Salles B, 1992, Toxicology, 72, 341, 10.1016/0300-483X(92)90184-G

Satoh M, 2003, J Pharmacol Exp Ther, 305, 1183, 10.1124/jpet.102.047522

Satoh T, 2001, Eur J Obstet Gynecol Reprod Biol, 96, 202, 10.1016/S0301-2115(00)00473-5

Schafer FQ, 2001, Free Radic Biol Med, 30, 1191, 10.1016/S0891-5849(01)00480-4

Scheel-Toellner D, 2004, Blood, 104, 2557, 10.1182/blood-2004-01-0191

Schweyer S, 2004, Int J Oncol, 25, 1671

Scorrano L, 2003, Science, 300, 135, 10.1126/science.1081208

Sedletska Y, 2005, Curr Med Chem Anticancer Agents, 5, 251, 10.2174/1568011053765967

10.4161/cbt.4.7.1783

Sharma R, 1993, Cancer Lett, 75, 111, 10.1016/0304-3835(93)90195-F

Shimizu T, 2008, Anticancer Res, 28, 75

Shimizu T, 2004, Proc Natl Acad Sci U SA, 101, 6770, 10.1073/pnas.0401604101

Siddik ZH., 2003, Oncogene, 22, 7265, 10.1038/sj.onc.1206933

10.1016/0925-4439(95)00010-2

Soderdahl T, 2003, FASEB J, 17, 124, 10.1096/fj.02-0259fje

Stewart DJ., 2007, Crit Rev Oncol Hematol, 63, 12, 10.1016/j.critrevonc.2007.02.001

Stewart JHT, 2007, J Surg Res, 141, 120, 10.1016/j.jss.2007.03.048

Surowiak P, 2005, Virchows Arch, 447, 626, 10.1007/s00428-005-1228-0

10.1016/j.semcancer.2008.12.002

10.2174/1389200013338289

Thomenius MJ, 2003, J Cell Sci, 116, 4493, 10.1242/jcs.00829

Torigoe T, 2005, Curr Med Chem Anticancer Agents, 5, 15, 10.2174/1568011053352587

Townsend DM, 2003, Oncogene, 22, 7369, 10.1038/sj.onc.1206940

Townsend D.M, 2003, Biomed Pharmacother, 57, 145, 10.1016/S0753-3322(03)00043-X

van der Zee AG, 1995, J Clin Oncol, 13, 70, 10.1200/JCO.1995.13.1.70

10.1016/j.dnarep.2005.03.002

10.1111/1523-1747.ep12614831

10.1016/S0891-5849(99)00174-4

Voehringer DW, 2000, Proc Natl Acad Sci U S A, 97, 2680, 10.1073/pnas.97.6.2680

Voehringer DW, 1998, Drug Resist Updat, 1, 345, 10.1016/S1368-7646(98)80010-1

Voehringer DW, 2000, Antioxid Redox Signal, 2, 537, 10.1089/15230860050192314

Warmann SW, 2008, J Surg Res, 144, 43, 10.1016/j.jss.2007.03.054

10.1158/1078-0432.CCR-06-1037

Yi X, 2003, J Biol Chem, 278, 16992, 10.1074/jbc.M300039200

Yip KW, 2008, Oncogene, 27, 6398, 10.1038/onc.2008.307

Zamble DB, 1995, Trends Biochem Sci, 20, 435, 10.1016/S0968-0004(00)89095-7